LanzaTech Global (NASDAQ:LNZA) Issues Quarterly Earnings Results, Beats Estimates By $6.43 EPS
LanzaTech Global (NASDAQ:LNZA – Get Free Report) issued its quarterly earnings results on Tuesday. The company reported ($0.04) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($6.47) by $6.43, Zacks reports. The business had revenue of $28.00 million during the quarter, compared to analyst estimates of $12.20 million. LanzaTech Global Trading […]
Beyond Meat (NASDAQ:BYND) Releases Quarterly Earnings Results, Misses Estimates By $0.17 EPS
Beyond Meat (NASDAQ:BYND – Get Free Report) announced its quarterly earnings results on Tuesday. The company reported ($0.29) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.12) by ($0.17), FiscalAI reports. The firm had revenue of $61.59 million during the quarter, compared to analysts’ expectations of $63.00 million. Here are the […]
Nuvve (NASDAQ:NVVE) Announces Quarterly Earnings Results, Beats Estimates By $1,913.62 EPS
Nuvve (NASDAQ:NVVE – Get Free Report) issued its earnings results on Tuesday. The company reported ($6.38) earnings per share (EPS) for the quarter, topping the consensus estimate of ($1,920.00) by $1,913.62, FiscalAI reports. The company had revenue of $1.95 million for the quarter, compared to the consensus estimate of $1.90 million. Here are the key […]
GoHealth (NASDAQ:GOCO) Releases Quarterly Earnings Results, Beats Estimates By $1.66 EPS
GoHealth (NASDAQ:GOCO – Get Free Report) released its quarterly earnings results on Tuesday. The company reported ($1.03) earnings per share (EPS) for the quarter, beating the consensus estimate of ($2.69) by $1.66, FiscalAI reports. GoHealth had a negative net margin of 26.95% and a positive return on equity of 8.00%. The firm had revenue of […]
Omeros (NASDAQ:OMER) Releases Earnings Results, Beats Estimates By $3.69 EPS
Omeros (NASDAQ:OMER – Get Free Report) issued its quarterly earnings data on Tuesday. The biopharmaceutical company reported $3.14 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.55) by $3.69, FiscalAI reports. Here are the key takeaways from Omeros’ conference call: Omeros closed an asset sale and license with Novo Nordisk for phase […]
Lulu’s Fashion Lounge (NASDAQ:LVLU) Posts Quarterly Earnings Results, Beats Estimates By $1.21 EPS
Lulu’s Fashion Lounge (NASDAQ:LVLU – Get Free Report) announced its quarterly earnings results on Monday. The company reported ($0.14) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($1.35) by $1.21, Zacks reports. Lulu’s Fashion Lounge had a negative net margin of 15.83% and a negative return on equity of 251.91%. The […]
Cocrystal Pharma (NASDAQ:COCP) Issues Quarterly Earnings Results, Beats Estimates By $0.01 EPS
Cocrystal Pharma (NASDAQ:COCP – Get Free Report) posted its earnings results on Tuesday. The company reported ($0.17) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.18) by $0.01, FiscalAI reports. Cocrystal Pharma Stock Down 2.9% COCP opened at $1.00 on Tuesday. Cocrystal Pharma has a 12-month low of $0.86 and a […]
DiaMedica Therapeutics (NASDAQ:DMAC) Posts Earnings Results, Beats Estimates By $0.02 EPS
DiaMedica Therapeutics (NASDAQ:DMAC – Get Free Report) posted its quarterly earnings data on Monday. The company reported ($0.16) earnings per share for the quarter, topping the consensus estimate of ($0.18) by $0.02, FiscalAI reports. DiaMedica Therapeutics Price Performance Shares of NASDAQ DMAC traded down $0.15 during mid-day trading on Monday, hitting $6.64. The company had […]
PDS Biotechnology (NASDAQ:PDSB) Announces Quarterly Earnings Results, Beats Estimates By $0.06 EPS
PDS Biotechnology (NASDAQ:PDSB – Get Free Report) issued its quarterly earnings results on Monday. The company reported ($0.14) EPS for the quarter, beating analysts’ consensus estimates of ($0.20) by $0.06, FiscalAI reports. PDS Biotechnology Stock Performance NASDAQ:PDSB opened at $0.54 on Monday. PDS Biotechnology has a 12 month low of $0.52 and a 12 month […]
Reviva Pharmaceuticals (NASDAQ:RVPH) Posts Earnings Results, Beats Estimates By $0.37 EPS
Reviva Pharmaceuticals (NASDAQ:RVPH – Get Free Report) released its quarterly earnings results on Saturday. The company reported $0.32 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.05) by $0.37, FiscalAI reports. Reviva Pharmaceuticals Price Performance Shares of RVPH opened at $0.74 on Monday. The business has a fifty day moving average […]
Aptevo Therapeutics (NASDAQ:APVO) Posts Quarterly Earnings Results, Beats Estimates By $126.33 EPS
Aptevo Therapeutics (NASDAQ:APVO – Get Free Report) posted its quarterly earnings data on Friday. The biotechnology company reported $118.23 earnings per share for the quarter, topping analysts’ consensus estimates of ($8.10) by $126.33, FiscalAI reports. Aptevo Therapeutics Stock Down 5.3% Aptevo Therapeutics stock opened at $4.27 on Friday. Aptevo Therapeutics has a 52-week low of […]
MeiraGTx (NASDAQ:MGTX) Posts Quarterly Earnings Results, Beats Estimates By $0.79 EPS
MeiraGTx (NASDAQ:MGTX – Get Free Report) released its quarterly earnings results on Thursday. The company reported $0.19 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.60) by $0.79, Zacks reports. The business had revenue of $75.36 million for the quarter, compared to analyst estimates of $3.87 million. MeiraGTx had a negative […]
Lovesac (NASDAQ:LOVE) Posts Quarterly Earnings Results, Beats Estimates By $0.19 EPS
Lovesac (NASDAQ:LOVE – Get Free Report) released its quarterly earnings results on Thursday. The company reported $2.19 earnings per share for the quarter, topping the consensus estimate of $2.00 by $0.19, RTT News reports. The firm had revenue of $248.05 million for the quarter, compared to analysts’ expectations of $242.77 million. Lovesac had a net […]
Oramed Pharmaceuticals (NASDAQ:ORMP) Issues Quarterly Earnings Results, Beats Estimates By $0.02 EPS
Oramed Pharmaceuticals (NASDAQ:ORMP – Get Free Report) released its quarterly earnings results on Thursday. The biotechnology company reported ($0.06) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.02, Zacks reports. Oramed Pharmaceuticals Price Performance Shares of ORMP stock traded down $0.03 on Friday, hitting $3.29. The stock had a […]
SBC Medical Group (NASDAQ:SBC) Issues Earnings Results, Beats Estimates By $0.01 EPS
SBC Medical Group (NASDAQ:SBC – Get Free Report) issued its earnings results on Friday. The company reported $0.14 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.13 by $0.01, FiscalAI reports. SBC Medical Group had a net margin of 24.28% and a return on equity of 24.17%. The company had revenue […]
Dermata Therapeutics (NASDAQ:DRMA) Releases Quarterly Earnings Results, Beats Estimates By $0.02 EPS
Dermata Therapeutics (NASDAQ:DRMA – Get Free Report) issued its quarterly earnings data on Thursday. The company reported ($1.52) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($1.54) by $0.02, FiscalAI reports. Dermata Therapeutics Price Performance Shares of DRMA stock opened at $1.37 on Friday. Dermata Therapeutics has a one year low […]
Zentalis Pharmaceuticals (NASDAQ:ZNTL) Releases Quarterly Earnings Results, Misses Estimates By $0.08 EPS
Zentalis Pharmaceuticals (NASDAQ:ZNTL – Get Free Report) issued its earnings results on Thursday. The company reported ($0.49) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.41) by ($0.08), FiscalAI reports. Zentalis Pharmaceuticals Stock Performance NASDAQ:ZNTL traded up $0.12 during mid-day trading on Thursday, hitting $2.67. The company had a trading volume […]
Vivani Medical (NASDAQ:VANI) Releases Earnings Results, Beats Estimates By $0.01 EPS
Vivani Medical (NASDAQ:VANI – Get Free Report) announced its earnings results on Thursday. The company reported ($0.09) EPS for the quarter, topping the consensus estimate of ($0.10) by $0.01, FiscalAI reports. Vivani Medical Stock Down 4.4% Shares of VANI traded down $0.05 during midday trading on Thursday, reaching $1.08. 270,967 shares of the stock were […]
Lovesac (NASDAQ:LOVE) Releases Earnings Results, Beats Estimates By $0.01 EPS
Lovesac (NASDAQ:LOVE – Get Free Report) posted its quarterly earnings results on Thursday. The company reported $2.19 EPS for the quarter, beating the consensus estimate of $2.18 by $0.01, RTT News reports. Lovesac had a net margin of 1.05% and a return on equity of 3.61%. During the same period last year, the firm posted […]
SeaStar Medical (NASDAQ:ICU) Posts Earnings Results, Beats Estimates By $0.17 EPS
SeaStar Medical (NASDAQ:ICU – Get Free Report) issued its quarterly earnings data on Wednesday. The company reported ($0.80) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.97) by $0.17, FiscalAI reports. SeaStar Medical had a negative return on equity of 414.50% and a negative net margin of 1,551.08%.The business had revenue of […]
Exicure (NASDAQ:XCUR) Releases Earnings Results, Beats Estimates By $18.14 EPS
Exicure (NASDAQ:XCUR – Get Free Report) posted its quarterly earnings data on Wednesday. The company reported ($0.46) EPS for the quarter, beating analysts’ consensus estimates of ($18.60) by $18.14, FiscalAI reports. Exicure Price Performance Shares of NASDAQ:XCUR traded up $0.02 during midday trading on Wednesday, hitting $4.49. The company had a trading volume of 16,841 […]
Noodles & Company (NASDAQ:NDLS) Announces Quarterly Earnings Results, Beats Estimates By $0.29 EPS
Noodles & Company (NASDAQ:NDLS – Get Free Report) posted its quarterly earnings results on Wednesday. The restaurant operator reported ($0.43) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.72) by $0.29, FiscalAI reports. The company had revenue of $122.78 million for the quarter, compared to the consensus estimate of $122.40 million. […]
Paysign (NASDAQ:PAYS) Releases Quarterly Earnings Results, Misses Estimates By $0.01 EPS
Paysign (NASDAQ:PAYS – Get Free Report) issued its earnings results on Tuesday. The company reported $0.02 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.03 by ($0.01), FiscalAI reports. The firm had revenue of $22.76 million during the quarter, compared to analysts’ expectations of $21.54 million. Paysign had a return on […]
Bionano Genomics (NASDAQ:BNGO) Posts Earnings Results, Beats Estimates By $0.78 EPS
Bionano Genomics (NASDAQ:BNGO – Get Free Report) announced its quarterly earnings results on Monday. The company reported ($0.03) EPS for the quarter, beating the consensus estimate of ($0.81) by $0.78, FiscalAI reports. The firm had revenue of ($20,528.49) million for the quarter, compared to analyst estimates of $7.88 million. Bionano Genomics had a negative return […]
Palisade Bio (NASDAQ:PALI) Announces Quarterly Earnings Results, Beats Estimates By $1.10 EPS
Palisade Bio (NASDAQ:PALI – Get Free Report) released its quarterly earnings results on Friday. The company reported $1.08 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.02) by $1.10, FiscalAI reports. Palisade Bio Stock Down 5.0% NASDAQ:PALI traded down $0.10 on Friday, hitting $1.89. The stock had a trading volume of 2,899,742 […]
Assembly Biosciences (NASDAQ:ASMB) Posts Quarterly Earnings Results, Beats Estimates By $2.99 EPS
Assembly Biosciences (NASDAQ:ASMB – Get Free Report) announced its quarterly earnings data on Thursday. The biopharmaceutical company reported $2.48 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.51) by $2.99, FiscalAI reports. The company had revenue of $42.47 million for the quarter, compared to analyst estimates of $7.42 million. Assembly Biosciences had […]
Satellogic (NASDAQ:SATL) Releases Quarterly Earnings Results, Beats Estimates By $0.23 EPS
Satellogic (NASDAQ:SATL – Get Free Report) posted its quarterly earnings data on Thursday. The company reported $0.17 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.06) by $0.23, FiscalAI reports. The company had revenue of $6.25 million for the quarter, compared to analyst estimates of $3.83 million. Here are the key […]
last updated on 3 Apr 05:02